【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Colorectal Cancer Overview 17
3 Products under Development 18
3.1 Colorectal Cancer – Pipeline Products by Stage of Development 18
3.2 Colorectal Cancer – Pipeline Products by Territory 19
3.3 Colorectal Cancer – Pipeline Products by Regulatory Path 20
3.4 Colorectal Cancer – Pipeline Products by Estimated Approval Date 21
3.5 Colorectal Cancer – Ongoing Clinical Trials 22
4 Colorectal Cancer – Pipeline Products under Development by Companies 23
4.1 Colorectal Cancer Companies – Pipeline Products by Stage of Development 23
4.2 Colorectal Cancer – Pipeline Products by Stage of Development 28
5 Colorectal Cancer Companies and Product Overview 33
5.1 A2K Technologies Company Overview 33
5.2 Abbott Diagnostics Company Overview 34
5.3 Advanced Marker Discovery, S.L. Company Overview 40
5.4 Advpharma Inc. Company Overview 41
5.5 Ambergen, Inc. Company Overview 42
5.6 Ambrilia Biopharma Inc. Company Overview 44
5.7 Applied Proteomics, Inc. Company Overview 45
5.8 Arizona State University Company Overview 46
5.9 ArtemixRx Company Overview 47
5.10 Asuragen, Inc. Company Overview 48
5.11 Bio Mark Ltd Company Overview 49
5.12 Biocartis SA Company Overview 50
5.13 Biodesix Inc. Company Overview 51
5.14 BioMarCare Technologies Ltd. Company Overview 52
5.15 BioMark Diagnostics Inc. Company Overview 54
5.16 BioMark Technologies Inc. Company Overview 55
5.17 BioMarker Strategies, LLC Company Overview 56
5.18 bioMerieux S.A. Company Overview 57
5.19 Biomoda, Inc. (Inactive) Company Overview 59
5.20 Biosceptre (Aust) Pty Ltd Company Overview 60
5.21 BioSystems International Company Overview 61
5.22 Biotechnostics GmbH Company Overview 62
5.23 Biotron Limited Company Overview 63
5.24 Castle Biosciences Incorporated Company Overview 65
5.25 Cellmid Limited Company Overview 66
5.26 Ceres Nanosciences, Inc. Company Overview 69
5.27 Cernostics Inc. Company Overview 70
5.28 ChemImage Corporation Company Overview 71
5.29 China Sky One Medical, Inc. Company Overview 73
5.30 Chinese University of Hong Kong Company Overview 74
5.31 Chronix Biomedical, Inc. Company Overview 76
5.32 Cleveland Diagnostics Inc. Company Overview 77
5.33 ColoPrev Company Overview 78
5.34 Columbia University Company Overview 79
5.35 Courtagen Life Sciences, Inc. Company Overview 80
5.36 CS-Keys, Inc. Company Overview 81
5.37 Dartmouth College Company Overview 82
5.38 Di.V.A.L Toscana srl Company Overview 84
5.39 diaDexus, Inc. Company Overview 85
5.40 DiagnoCure Inc. Company Overview 89
5.41 Diaxonhit S.A. Company Overview 92
5.42 EDP Biotech Corporation Company Overview 94
5.43 Epigenomics AG Company Overview 95
5.44 Eureka Genomics Corporation Company Overview 99
5.45 Eventus Diagnostics, Inc. Company Overview 100
5.46 Exact Sciences Corporation Company Overview 101
5.47 Exiqon A/S Company Overview 105
5.48 Exosomics Siena SpA Company Overview 108
5.49 Fina Biotech Company Overview 109
5.50 GenomicTree, Inc. Company Overview 110
5.51 Ghent University Company Overview 112
5.52 GlycoZym Company Overview 113
5.53 Health Discovery Corporation Company Overview 114
5.54 Human Metabolome Technologies, Inc. Company Overview 115
5.55 Ikonisys, Inc. Company Overview 116
5.56 Innovative Health Diagnostics Company Overview 117
5.57 IntegraGen SA Company Overview 119
5.58 InterGenetics Incorporated Company Overview 121
5.59 IV Diagnostics, Inc. Company Overview 122
5.60 Lab21 Limited Company Overview 123
5.61 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 124
5.62 LX Diagnostics Company Overview 125
5.63 MabCure Inc. Company Overview 126
5.64 Matrix-Bio, Inc. Company Overview 127
5.65 Mayo Clinic Company Overview 130
5.66 MDxHealth SA Company Overview 131
5.67 Metabiomics Corporation Company Overview 134
5.68 Metabolomic Technologies Inc. Company Overview 135
5.69 Metabolon, Inc. Company Overview 137
5.70 MetaStat, Inc. Company Overview 138
5.71 Milagen, Inc. Company Overview 140
5.72 Miraculins Inc. Company Overview 141
5.73 Mode Dx Ltd. Company Overview 143
5.74 Myriad Genetics, Inc. Company Overview 144
5.75 Nanosphere, Inc. Company Overview 146
5.76 Neogenix Oncology, Inc. Company Overview 148
5.77 NetScientific Plc Company Overview 151
5.78 Norda ASA Company Overview 152
5.79 Novel Bio-spectrum Technologies, Inc. Company Overview 154
5.80 Nuclea Biotechnologies Inc. Company Overview 155
5.81 Nuvera Biosciences, Inc. Company Overview 156
5.82 OncoVista Innovative Therapies, Inc. Company Overview 157
5.83 On-Q-ity, Inc. (Inactive) Company Overview 159
5.84 Origin Sciences Limited Company Overview 160
5.85 Orion Genomics LLC Company Overview 161
5.86 OTraces Inc. Company Overview 163
5.87 Oxford Cancer Biomarkers Company Overview 164
5.88 Oxford Gene Technology Limited Company Overview 165
5.89 Pacific Edge Limited Company Overview 166
5.90 Panacea Pharmaceuticals, Inc. Company Overview 167
5.91 PleX Diagnostics Company Overview 168
5.92 Prediction Sciences Company Overview 169
5.93 Protagen AG Company Overview 170
5.94 Rosetta Genomics, Ltd. Company Overview 171
5.95 Scienion AG Company Overview 172
5.96 Seegene, Inc. Company Overview 173
5.97 Shuwen Biotech Co. Ltd. Company Overview 175
5.98 Siamab Therapeutics, Inc. Company Overview 176
5.99 Sienna Cancer Diagnostics Ltd Company Overview 177
5.100 Skuldtech France Company Overview 178
5.101 Sysmex Corporation Company Overview 179
5.102 Tel Aviv University Company Overview 181
5.103 Texas A&M University Company Overview 182
5.104 The Johns Hopkins University Company Overview 183
5.105 TheraDiag SA Company Overview 185
5.106 Todos Medical Company Overview 189
5.107 Universite De Lyon Company Overview 190
5.108 University of Alabama at Birmingham Company Overview 191
5.109 University of Chicago Company Overview 194
5.110 University of Texas at Austin Company Overview 195
5.111 US Biomarkers, Inc. Company Overview 196
5.112 Vanderbilt University Company Overview 197
5.113 Vermillion, Inc. Company Overview 201
5.114 Viomics Inc. Company Overview 203
5.115 Vitatex Inc. Company Overview 204
5.116 VolitionRX Ltd. Company Overview 206
5.117 XEPTAGEN SpA Company Overview 210
6 Colorectal Cancer- Recent Developments 212
7 Appendix 253
7.1 Methodology 253
7.2 About GlobalData 255
7.3 Contact Us 256
7.4 Disclaimer 256
【レポート販売概要】
■ タイトル：世界における大腸がん検査製品のパイプライン動向2015■ 英文：Colorectal Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0082EPD
■ 調査対象地域：グローバル
- Taiwan Pharmaceutical Market Outlook 2013Taiwan Pharmaceutical Market Outlook 2013 Summary GBI Research, the leading business intelligence provider, has released its latest research "Taiwan Pharmaceutical Market Outlook 2013". The report focuses on the Taiwanese pharmaceutical market, providing market analysis and a forecast to 2018. It provides details on the various market drivers and healthcare trends that influence growth in Taiwan’s …
- アメリカの宝くじ市場2016-2020About Lottery in the US Lottery is banned in various states in the US mainly due to its impacts on the society. The purchase of lottery can be addictive, hence impacting the livelihood of many. However, due to easier ROI, the demand for lottery has increased. Higher jackpot values have raised the demand for tickets with larger jackpot amount in state lotteries of the US. This lures casual players …
- STEM（科学・技術・工学・数学）玩具の世界市場2019-2023About this market Rising application of Al in STEM toys to drive market growth. The application of artificial intelligence (Al) in STEM toys has grown over the last few years. Al-powered STEM toys are becoming popular, especially among working parents. This is because these toys act as learning companions for children and offer customizability for a range of lessons in core STEM disciplines and co …
- 航空機用座席の世界市場予測（～2025年）Increasing demand for seats installed with in-flight entertainment systems is one of the significant factors driving the growth of the aircraft seating market across the globe. The aircraft seating market is projected to grow from USD 6.4 billion in 2018 to USD 10.5 billion by 2025, at a CAGR of 7.25% during the forecast period from 2018 to 2025. This market’s growth can be attributed to the incre …
- 血小板凝集デバイスの世界市場：装置、試薬、消耗品、付属品The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) hold large shares in the global platelet aggregation devices market, and the North American region (particularly the U.S.) is expected to grow at the …
- メープルウォーターの世界市場2016-2020About Maple Water Maple water is the sap extracted from maple trees. It is a natural source of hydration and nutrients and is naturally filtered from maple trees. The maple sap is usually harvested in the spring season as stem pressure in maple is dependent on temperature — many freeze–thaw cycles are required to initiate positive pressure. The sap is majorly used for the preparation of maple syru …
- ペイメントゲートウェイの世界市場2016-2020About Payment Gateways Payment gateways enable credit card payments for e-businesses, online retailers, bricks and clicks, and traditional brick-and-mortar businesses. They help in the exchange of information between a payment portal — website, mobile phone, or Interactive voice response service — and the bank, which processes credit card transactions. They work securely to transfer sensitive cred …
- 帯状ヘルペス(シングルス)(Herpes Zoster (Shingles))：治療薬開発パイプライン動向（2015年上半期版）Herpes Zoster (Shingles) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H1 2015’, provides an overview of the Herpes Zoster (Shingles)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessme …
- グリセリド・エトキシレートの世界市場The report covers the global glyceride ethoxylate market. This market has been segmented based on application and geography. The market data for these types is given with respect to volume (KT) and value (USD Million). The global glyceride ethoxylate market was valued at $640.7 million in 2014, and is projected to reach $720.5 million by 2019, at a CAGR of 2.4% from 2014 to 2019. The total market …
- 水酸化鉄の世界市場2015Ferric hydroxide (CAS 1309-33-7) Market Research Report 2015 aims at providing comprehensive data on Ferric hydroxide market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Ferric hydroxide description, covers its application areas, manufacturing methods, patterns. It captures Ferric hydroxide market trends, pays close attention to Ferric hydroxide man …
- 世界の発電機レンタル市場動向（2012-2016）TechNavio's analysts forecast the Global Power Rental market to grow at a CAGR of 17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing energy demand. The Global Power Rental market has also been witnessing an increasing demand for electricity. However, stringent emission regulations could pose a challenge to the growth of this market. Te …
- デュシェンヌ型筋ジストロフィー治療薬の世界市場機会分析OpportunityAnalyzer: Duchenne Muscular Dystrophy - Opportunity and Market Analysis to 2019 Summary Duchenne muscular dystrophy (DMD) is a rare genetic disorder affecting approximately 1 in 3,500 newborn boys and is characterized by progressive muscle degeneration, loss of ambulation, and death by the late 20s. There are no marketed pharmacological therapies that are indicated for DMD. The current …
- ココナッツウォーターの世界市場2015-2019About coconut water Coconut water is a clear liquid extracted from unripe (green) coconuts. It is technically called a fruit juice and is a popular drink among consumers in tropical countries. In many countries such as India, Sri Lanka, and Thailand, the juice is commonly sold fresh by street vendors. Packaged coconut water is prepared by extracting liquid from selected tender fresh coconuts throu …
- 世界の香料（香水）製品市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global fragrances market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global fragrances market throughout the month. Additionally, the report provides an overview of all the partne …
- 呼吸ケア装置の世界市場予測（～2024年）“High prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population is expected to drive the growth of the respiratory care devices market.” The respiratory care devices market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1%. The rapid growth in the global geriatric population, rising incidence of chronic disea …
